{"id":97021,"date":"2020-07-01T07:41:06","date_gmt":"2020-07-01T07:41:06","guid":{"rendered":"https:\/\/www.edristi.in\/?p=97021"},"modified":"2020-07-01T07:41:09","modified_gmt":"2020-07-01T07:41:09","slug":"covaxin-first-potential-covid-19-vaccine-developed-in-the-country","status":"publish","type":"post","link":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/covaxin-first-potential-covid-19-vaccine-developed-in-the-country\/","title":{"rendered":"COVAXIN, first potential COVID-19 Vaccine developed in the country"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Question:On June 29, 2020, Central Drug Standard Control Organisation has granted approval to conduct human clinical trials for Corona Vaccine called \u2018Covaxin\u2019.\u00a0By whom it has been developed?<\/strong> <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">(a)\u00a0\u00a0\u00a0 Glenmark <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">(b)\u00a0\u00a0 Cipla <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">(c)\u00a0\u00a0\u00a0 Lupin  <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">(d)\u00a0\u00a0 NIV, Pune &amp; Bharat Biotech <\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Answer: (d) <\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Related facts: <\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\"><li> The Central Drug Standard Control Organisation, the National regulatory body for Indian Pharmaceuticals and medical devices, has granted approval to Bharat Biotech India to conduct human clinical trials for Corona Vaccine called \u2018Covaxin\u2019.<\/li><li>It is the first indigenous COVID-19 vaccine to receive the approval.  <\/li><li>The Covaxin has been developed in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV), Pune.<\/li><li>The Drug Controller General of India approved Bharat Biotech\u2019s application to conduct phase I and II clinical trials for Covaxin. \u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 The permission was granted after the company submitted results from pre-clinical studies of the vaccine that demonstrated its safety and immune response.<\/li><li>The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech.<\/li><li>The indigenous, inactivated vaccine developed and manufactured at the Bio-safety level 3 lab of the Bharat Biotech located in Genome Valley in Hyderabad. <\/li><\/ul>\n\n\n\n<p class=\"has-text-align-right wp-block-paragraph\"><strong>By-Amar Mani Upadhyay<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Links: <\/strong><a href=\"http:\/\/www.newsonair.com\/News?title=DGCI-gives-approval-for-human-clinical-trials-of-COVAXIN%2C-first-potential-COVID-19-Vaccine-developed-in-the-country&amp;id=392580\ufffc\">http:\/\/www.newsonair.com\/News?title=DGCI-gives-approval-for-human-clinical-trials-of-COVAXIN%2C-first-potential-COVID-19-Vaccine-developed-in-the-country&amp;id=392580<span style=\"font-family: Arial, sans-serif;letter-spacing: 0.4pt;background-image: initial;background-position: initial;background-size: initial;background-attachment: initial\"><\/span> <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Question:On June 29, 2020, Central Drug Standard Control Organisation has granted approval to conduct human clinical trials for Corona Vaccine called \u2018Covaxin\u2019.\u00a0By whom it has been developed? (a)\u00a0\u00a0\u00a0 Glenmark (b)\u00a0\u00a0 Cipla (c)\u00a0\u00a0\u00a0 Lupin (d)\u00a0\u00a0 NIV, Pune &amp; Bharat Biotech Answer: (d) Related facts: The Central Drug Standard Control Organisation, the National regulatory body for Indian [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":97022,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[1121],"tags":[2344],"class_list":["post-97021","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-nnews","tag-national"],"jetpack_publicize_connections":[],"jetpack_shortlink":"https:\/\/wp.me\/phvHKS-peR","jetpack_likes_enabled":true,"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.edristi.in\/wp-content\/uploads\/2020\/07\/nationalCOVAXIN.jpg?fit=300%2C168&ssl=1","_links":{"self":[{"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/posts\/97021","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/comments?post=97021"}],"version-history":[{"count":0,"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/posts\/97021\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/media\/97022"}],"wp:attachment":[{"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/media?parent=97021"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/categories?post=97021"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.edristi.in\/hi\/%e0%a4%b9%e0%a5%8b%e0%a4%ae\/wp-json\/wp\/v2\/tags?post=97021"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}